Canada:
Supreme Court Of Canada Denies Leave To Hear Section 8 Case
15 June 2012
Beeser Ramamoorthy LLP
To print this article, all you need is to be registered or login on Mondaq.com.
On June 14, 2012, the Supreme Court of Canada ("SCC")
denied leave to hear an appeal involving section 8 of the Patented
Medicines (Notice of Compliance) Regulations. The case involves
Merck and Apotex regarding the drug lovastatin. The SCC's
summary of the leave case can be found
here.
Consistent with its practice, the SCC did not provide reasons
for the denial of the leave application.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from Canada
Moral Right To Authorship Tied To Copyright
Oyen Wiggs Green & Mutala LLP
The Federal Court of Appeal has upheld a finding that the Royal Canadian Legion did not infringe an author's moral rights by selling poppy patterned...
Case Review 2023: Patent Motions
Seastone IP
In 2023, the Federal Court of Canada released more patent motion decisions than motion decisions in all other IP rights combined...